|
Home
Osteo Arthritis Research Society International OARSI
OsteoArthritis Research Society International (OARSI)
15000 Commerce Parkway, Suite C
Mt. Laurel, NJ 08054, USA
E-mail: oarsi@oarsi.org
Tel:: 856-439-1385
Fax: 856-439-0525
OARSI Staff
Diann Stern, MS, CAE
Executive Director
Ph: 856-642-4214
Priscilla Rodriguez
Administrative Assistant/Membership
Ph: 856-642-4215
Anthony Celenza, CMP
Meeting Manager
Ph: 856-642-4431
Mission
OARSI is the premier international organization for scientists and health care professionals focused on the prevention and treatment of osteoarthritis through the promotion and presentation of research, education and the worldwide dissemination of new knowledge.
Strategic Goals
To further the mission the Board also approved strategic goals for the next five years:
- To increase OARSI visibility through member involvement. We will increase the number of committees to include more members and establish a committee rotation policy. We will focus on mentoring young scientists and will be establishing action steps to help us reach this goal.
- To provide quality educational opportunities and disseminate research. OARSI will develop a scholarship program for young investigators enabling them to study in another continent. In addition, we continue to work on translation and dissemination of the treatment guidelines for hip and knee OA that were published in early 2008. We have also established an OARSI-OMERACT Ultrasound study group and a new biomarkers initiative. The website committee is working on developing a searchable slide set that can be used for educational purposes.
- To establish standards and tools for health care and research in OA. OARSI was awarded the FDA project to conduct and manage the coordination of a critical appraisal of certain fundamentals of the science related to the design of clinical development programs for human drugs, biological products, and medical devices for the treatment and prevention of OA in addition to issues regarding clinical outcomes measured as improvements in signs and symptoms, function and structural modification. Workgroups have been formed and public hearings will be scheduled, with a final report issued in two years. In addition, an Atlas on Histology of Animal Models in Osteoarthritis will be produced early in 2009.
- To develop strategic alliances. OARSI is working with many groups including the Arthritis Foundation and Canadian Arthritis Network for the Biomarkers initiatives. Following up on the successful NIAMS/NIA sponsored Biomarkers Network Workshops in 2004, 2005 and 2006, three additional OA Biomarker Workshops are planned over the next four years.
- To maintain financial stability. The Board of Directors has the fiduciary responsibility for the OARSI funds and takes this responsibility very seriously. We monitor the finances and seek sponsorship and funding to help offset program costs.
History & Overview
The OsteoArthritis Research Society International (OARSI) was convened in 1990 (then Osteoarthritis Research Society) to promote and encourage fundamental and applied research, and to disseminate the results of that research in order to permit better knowledge of osteoarthritis and of its treatment.
In order to accomplish this goal, OARSI sponsors yearly conferences and/or workshops; an academically superb journal, Osteoarthritis and Cartilage; a newsletter covering Society business as well as medical and research developments; and important committees, such as the Osteoarthritis Clinical Trials Design Task Force.
OARSI members - physicians, researchers, and other health industry personnel from around the world who have an interest in bone, synovium and cartilage - are integral to spreading the concepts, hypotheses and developments concerning osteoarthritis among the international rheumatology community. This includes defining common criteria to assess activity of products on joints and osteoarthritis as well as encouraging dialogue with health administrators and authorities in order to prepare protocols and define common criteria.
A number of aspects led to the formation of OARSI. For instance, the increase in life-span around the world has resulted in osteoarthritis becoming more prevalent. In recent years, both clinical and basic research in osteoarthritis has increased, and osteoarthritis has become the leading reason of physical consultation in Europe.
Nevertheless, most rheumatic disease societies around the world focus on conditions other than osteoarthritis and few osteoarthritis abstracts are presented at rheumatology meetings. Osteoarthritis is the most common articular rheumatic disease, yet no previous organization specifically addressed its fundamental, clinical and pharmacologic aspects.
After many years of frustration, those interested in any and all aspects of osteoarthritis now have a vehicle that not only acknowledges their contributions, but promotes their learning and better understanding of osteoarthritis.
2009 OARSI
Osteoarthritis Research Society International
World Congress
Montreal, Canada
Sept 10 - 13 2009
2010 OARSI
Osteoarthritis Research Society International
World Congress
Brussels, Belgium
Sept 23 - 26 2010
2011 OARSI
Osteoarthritis Research Society International
World Congress
San Diego, California
Sept 15 - 18 2011
2012 OARSI
Osteoarthritis Research Society,
World Congress on Osteoarthritis,
Barcelona, Spain
Apr 26 - 29 2012
2013 OARSI
Osteoarthritis Research Society International,
2013 World Congress on Osteoarthritis,
Philadelphia, PA USA
Apr 25 - 28 2013
|
|
|